CYT
Price:
$3.02
Market Cap:
$108.71M
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company is also developing CYT-1853, which is in preclinical trials for solid tumors and hematologic malignancies. The company was incorporated in 2012 and is based in Lexington, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2021-06-18
Stock Exchange
NASDAQ
Ticker
CYT
According to Cyteir Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 21.89. This represents a change of -16.82% compared to the average of 26.31 of the last 4 quarters.
The mean historical Current Ratio of Cyteir Therapeutics, Inc. over the last ten years is 18.27. The current 21.89 Current Ratio has changed 11.88% with respect to the historical average. Over the past ten years (40 quarters), CYT's Current Ratio was at its highest in in the March 2023 quarter at 34.94. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
18.27
Median
20.57
Minimum
3.87
Maximum
28.07
Discovering the peaks and valleys of Cyteir Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 564.74%
Maximum Annual Current Ratio = 28.07
Minimum Annual Increase = -74.95%
Minimum Annual Current Ratio = 3.87
Year | Current Ratio | Change |
---|---|---|
2022 | 28.07 | 9.21% |
2021 | 25.71 | 564.74% |
2020 | 3.87 | -74.95% |
The current Current Ratio of Cyteir Therapeutics, Inc. (CYT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
19.22
5-year avg
18.27
10-year avg
18.27
Cyteir Therapeutics, Inc.’s Current Ratio is greater than Nuvation Bio Inc. (9.57), greater than Magenta Therapeutics, Inc. (14.64), greater than Neoleukin Therapeutics, Inc. (15.33), greater than Graphite Bio, Inc. (11.47), greater than Foghorn Therapeutics Inc. (4.77), greater than C4 Therapeutics, Inc. (6.31), greater than Prelude Therapeutics Incorporated (7.04), greater than Rezolute, Inc. (13.79), greater than Molecular Partners AG (14.33), greater than MediciNova, Inc. (16.66), greater than Anebulo Pharmaceuticals, Inc. (3.45), greater than Champions Oncology, Inc. (0.75), less than Eliem Therapeutics, Inc. (0), greater than HCW Biologics Inc. (0.07), greater than Monte Rosa Therapeutics, Inc. (6.03), greater than Nkarta, Inc. (12.91), greater than Lyell Immunopharma, Inc. (13.43), greater than Generation Bio Co. (6.34), greater than Sana Biotechnology, Inc. (4.47),
Company | Current Ratio | Market cap |
---|---|---|
9.57 | $949.12M | |
14.64 | $42.44M | |
15.33 | $8.20M | |
11.47 | $185.19M | |
4.77 | $279.08M | |
6.31 | $273.18M | |
7.04 | $64.12M | |
13.79 | $255.53M | |
14.33 | $195.74M | |
16.66 | $101.53M | |
3.45 | $42.01M | |
0.75 | $108.76M | |
0 | $342.68M | |
0.07 | $15.05M | |
6.03 | $433.13M | |
12.91 | $165.84M | |
13.43 | $179.07M | |
6.34 | $71.47M | |
4.47 | $390.72M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cyteir Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cyteir Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Cyteir Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Cyteir Therapeutics, Inc. (CYT)?
What is the highest Current Ratio for Cyteir Therapeutics, Inc. (CYT)?
What is the 3-year average Current Ratio for Cyteir Therapeutics, Inc. (CYT)?
What is the 5-year average Current Ratio for Cyteir Therapeutics, Inc. (CYT)?
How does the current Current Ratio for Cyteir Therapeutics, Inc. (CYT) compare to its historical average?